Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02645929 · ClinicalTrials.gov registry record

Reflective Function as a Mediator of Interpersonal Psychotherapy (IPT)

A clinical trial of PTSD, sponsored by New York State Psychiatric Institute.

Completed
Registry status
29
Enrollment target
1
Study location

NCT02645929: Completed study of PTSD, sponsored by New York State Psychiatric Institute.

NCT02645929 is a study of PTSD that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 29 participants, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02645929, a study of PTSD, has completed, sponsored by New York State Psychiatric Institute.

COMPLETED
Registry status
29 participants
Enrollment target
1
Study location

Study Summary

Our recent randomized controlled trial of psychotherapies for posttraumatic stress disorder (PTSD) showed that Interpersonal Psychotherapy (IPT) benefitted patients. The mechanism of action for IPT is unclear; unlike most PTSD therapies, it does not work through exposure to trauma reminders. This assessment study will assess Symptom-Specific Reflective Function, a measure of emotional awareness of one's PTSD symptoms, as a potential mediator of IPT, capitalizing on naturalistic treatment of military veterans with PTSD at Columbia University/New York State Psychiatric Institute.

Primary Outcome

The CAPS-5 is the standard measure for PTSD symptom severity

Conditions Studied

Interventions

  • BEHAVIORAL Interpersonal Psychotherapy (IPT)

Study Locations (1)

New York

  • New York State Psychiatric Institute - New York

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2016-04
Est. Completion 2020-05-01

What the finished NCT02645929 record still lists

NCT02645929 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (90% lower).

The record links to 1 condition, with PTSD appearing as the primary indexed condition, and to 1 intervention - of which Interpersonal Psychotherapy (IPT) is the first listed.

NCT02645929 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT02645929 about?

NCT02645929 is a clinical study titled "Reflective Function as a Mediator of Interpersonal Psychotherapy (IPT)". Our recent randomized controlled trial of psychotherapies for posttraumatic stress disorder (PTSD) showed that Interpersonal Psychotherapy (IPT) benefitted patients. The mechanism of action for IPT is unclear; unlike most PTSD therapies, it does not work through exposure to trauma reminders. This as...

What is the current status of trial NCT02645929?

This trial is currently completed. The enrollment target is 29 participants. The study started on 2016-04. Estimated completion is 2020-05-01.

What conditions does trial NCT02645929 study?

This clinical trial studies the following conditions: PTSD.

What interventions are being tested in trial NCT02645929?

The interventions under investigation include: Interpersonal Psychotherapy (IPT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT02645929?

This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02645929 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PTSD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02645929's enrollment target sits among peer trials

29 131st of 154 higher than 24 of 154 other PTSD trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other PTSD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02429557 · 29 participants · Phase 1

    Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure

  • NCT02568878 · 29 participants · Phase 3

    Creatine for Depressed Male and Female Methamphetamine Users

  • NCT03014401 · 29 participants · NA

    The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis

  • NCT03128996 · 29 participants · Phase 1

    Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02645929, the US trial registry maintained by the National Library of Medicine. NCT02645929 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.